Medicine · 2019 · 11 citations · 18 references
MedicineOncologySurgeryOncologic SurgerySurgical OncologyThoracic OncologyLung CancerLung Resection SurgeryPulmonary ResectionThoracic Oncology SurgeryThoracic SurgeryTumor Resection TechniquesLung Cancer ResectionMediastinal Lymph Node DissectionMinimally Invasive Lung ResectionRadical ResectionSystematic Review RetrievalThoracoscopic Cancer SurgeryThoracoscopic Lung SurgeryVideo-assisted Thoracic Surgery
BACKGROUND: Video-assisted thoracoscopic surgery (VATS) is a kind of minimally invasive surgery with the advantages of small surgical incision, less surgical bleeding, and fewer hospitalization days. However, traditional thoracotomy has advantages in lymph node dissection and radical resection of tumors and the benefits of VATS compared with thoracotomy for lung cancer are controversial. This systematic review and meta-analysis will be conducted to evaluate the advantages and disadvantages of the 2 different surgical methods. METHODS AND ANALYSIS: PubMed (Medline), Embase, Cochrane Central Register of Controlled Trials, and Google Scholar will be searched for relevant randomized controlled trials (RCTs), quasi-RCTs, and Hi-Q (high quality) prospective cohort trials published or unpublished in any language before March 1, 2019. Subgroup analysis will be performed in type of operation, tumor pathological stage, and ethnicity. RESULTS: The results of this study will be published in a peer-reviewed journal. CONCLUSION: As far as we know, this study will be the first time to compare and meta-analyze the efficacy of thoracoscopic lung cancer resection and thoracotomy. This study will provide high-quality and reliable evidence for clinicians' decision-making by comparing published or completed but unpublished trials data. Because of the characteristics of disease and intervention methods, large sample size and RCTs may be insufficient. We will carefully consider the inclusion of small sample RCTs, but this may lead to high heterogeneity and affect the reliability of research results. PROSPERO REGISTRATION NUMBER: CRD42018118427.
18
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins, Doug Altman, Peter C Gøtzsche et al. · BMJ · 2011 · 34.2K citations · Full text
Christina Fitzmaurice, Christine A. Allen, Ryan M Barber et al. · JAMA Oncology · 2016 · 6.3K citations · Full text
Subroto Paul, Nasser K. Altorki, Shubin Sheng et al. · Journal of Thoracic and Cardiovascular Surgery · 2010 · 798 citations · Full text